Profile on…
Prof. Mene
Pangalos

Pangalos’s collaborative approach to research sets him apart. Like the DISC, his leadership style emphasises the fostering of collaboration, innovation, and scientific rigour.

On his LinkedIn page, Pangalos writes, “We ensure we work seamlessly and inclusively, that our doors are always open, and our scientists can work in a permeable research environment, sharing ideas and collaborating with others.”

This progressive attitude has yielded significant results. When Pangalos took over, AstraZeneca was seen as one of the weakest R&D organisations in the industry.

He left it as one of the strongest, having increased R&D productivity almost six-fold and launched more medicines than ever before across all therapy areas.

These advances have transformed millions of patients’ lives. Reason enough to be considered as somebody deserving the title of ‘in search of wonder’.

Speaking on Pangalos’s retirement, Pascal Soriot, AstraZeneca’s CEO, said, “The quality of the medicines he has brought to patients, and the pipeline and capabilities he has built, will be his legacy for many years to come.”